Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing
View abstract on PubMed
Summary
This summary is machine-generated.This study identifies AP3S1 as a key driver gene in high-grade serous ovarian carcinoma (HGSOC), impacting patient survival and immune response. Findings offer new therapeutic targets for this aggressive cancer.
Area Of Science
- Oncology
- Genomics
- Molecular Biology
Background
- High-grade serous ovarian carcinoma (HGSOC) is an aggressive cancer with low survival rates, necessitating research into its molecular drivers.
- Whole-exome sequencing (WES) is crucial for identifying genetic alterations in cancer development.
Purpose Of The Study
- To compare the mutational landscape of HGSOC patients with TCGA data.
- To identify novel tumor driver genes and understand their functional roles in HGSOC.
- To explore potential therapeutic targets and molecular pathways for HGSOC.
Main Methods
- Analysis of whole-exome sequencing data from 90 ovarian cancer patients.
- Bioinformatics analysis to identify tumor driver genes and their functions.
- Experimental validation of bioinformatics findings, including gene knockdown studies.
Main Results
- Identified common mutations in BRCA1, BRCA2, and TP53 in HGSOC.
- AP3S1 was identified as the most significant tumor driver gene.
- AP3S1 mutations correlate with patient survival and tumor immune response, and regulate cell migration via the TGF-β/SMAD pathway.
Conclusions
- AP3S1 plays a critical role in HGSOC immunity and prognosis, offering potential for personalized treatment.
- This research deepens the understanding of HGSOC pathogenesis and supports the development of targeted interventions.
- Findings provide a basis for improving outcomes for patients with aggressive ovarian cancer.

